R. P. Downs, A. L. Chin, K. M. Dean, and J. D. Carrick
Vol 000
1H), 7.67 (d, J = 8.2 Hz, 2H), 7.59 (d, J = 8.2 Hz, 2H),
7.39–7.35 (Br–m, 1H), 7.22 (d, J = 8.2 Hz, 2H), 7.20 (d,
J = 8.2 Hz, 2H), 2.46 (s, 3H), 2.40 (s, 3H); 13C NMR
(125 MHz, CDCl3): δ = 160.5, 156.3, 155.9, 155.64,
155.6X (overlaps with 155.64), 152.7, 149.0, 141.5,
140.0, 138.2, 137.7, 133.1, 132.8, 130.0, 129.53, 129.5X
(overlaps with 129.53), 129.46, 124.4, 124.3, 122.9,
122.2, 21.7, 21.6; IR (ATR-CDCl3): ῡmax = 3058, 3025,
2921, 2863, 1675, 1607, 1581, 1561, 1493, 1381, 1361,
146.5, 145.1, 138.2, 137.5, 133.3, 133.0, 130.1, 129.6,
128.9, 128.8, 124.32, 124.26, 122.8, 122.2, 36.01,
35.96, 32.02, 32.01, 31.31, 31.25, 29.61, 29.58, 29.5X
(overlaps with 29.58), 29.43, 29.40, 29.4X (overlaps
with 29.40), 22.82, 22.81, 14.26, 14.2X (overlaps with
14.26); IR (ATR-CDCl3): ῡmax = 3056, 2926, 2854,
1610, 1581, 1493, 1468, 1431, 1381, 782 cmꢀ1; HRMS
(EI): m/z calculated for C41H45N5: 611.3988; found:
611.3998.
821, 782 cmꢀ1
; HRMS (EI): m/z calculated for
6-[5,6-Bis-(4-phenethylphenyl)[1,2,4]triazin-3-yl]-[2,20]bipyridinyl
C27H21N5: 415.1797; found: 415.1791.
(18). EtOAc/hexanes (gradient); pale-yellow solid; 1H NMR
6-[5,6-Bis-(4-butylphenyl)-[1,2,4]triazin-3-yl]-[2,20]bipyridinyl
(500 MHz, CDCl3): δ = 8.98 (Br–s, 1H), 8.83 (Br–s, 1H),
8.76 (d, J = 8.0 Hz, 1H), 8.16 (Br–t, J = 8.0 Hz, 1H),
7.66–7.63 (m, 2H), 7.59–7.56 (m, 2H), 7.29–7.24 (m, 7H),
7.21–7.13 (m, 10H), 3.00–2.91 (m, 8H); 13C NMR
(125 MHz, CDCl3): δ = 160.6, 156.3, 155.9, 155.6, 152.7,
148.69, 148.6X (overlaps with 148.69), 145.12, 143.8,
141.5, 141.3, 138.2, 137.8, 133.6, 133.2, 130.1, 129.6,
129.0, 128.9, 128.7, 128.6, 128.51, 128.49, 126.2, 124.4,
124.3, 123.0, 122.3, 37.91, 37.87, 37.7, 37.6; IR (ATR-
CDCl3): ῡmax = 3056, 3026, 2924, 2859, 1609, 1580,
1562, 1495, 1382, 1361, 825, 783, 748, 699 cmꢀ1; HRMS
(EI): m/z calculated for C41H33N5: 595.2736; found:
595.2728.
(15).
MeOH/DCM (gradient); yellow oil; 1H NMR
(500 MHz, CDCl3): δ = 8.84 (d, J = 8.0 Hz, 1H),
8.77–8.69 (m, 3H), 8.09 (t, J = 8.0 Hz, 1H), 7.99–
7.93 (Br–s, 1H), 7.70–7.66 (m, 2H), 7.62–7.58 (m,
2H), 7.45–7.39 (m, 1H), 7.24–7.18 (m, 4H), 2.69–2.63
(m, 4H), 1.67–1.58 (m, 4H), 1.42–1.32 (m, 4H), 0.98–
0.91 (m, 6H); 13C NMR (125 MHz, CDCl3):
δ = 160.5, 156.4, 156.0, 155.4, 152.8, 148.3, 146.5,
145.1, 138.3, 133.3, 133.0, 130.1, 129.6, 128.9, 128.8,
124.5, 124.5X (overlaps with 124.5), 124.4, 124.4X
(overlaps with 124.4), 123.1, 123.0, 35.72, 35.67, 33.5,
33.4, 22.50, 22.46, 14.11, 14.08; IR (ATR-CDCl3):
ῡmax = 3060, 3027, 2956, 2930, 2859, 1609, 1581,
1493, 1467, 1381, 1360, 834, 782, 732 cmꢀ1; HRMS
(EI): m/z calculated for C33H33N5: 499.2736; found:
499.2730.
6-[5,6-Bis-(3-methoxy-phenyl)-[1,2,4]triazin-3-yl]-[2,20]
bipyridinyl (19).
EtOAc/hexanes (gradient); yellow solid;
mp = 134.2–138.8°C; 1H NMR (500 MHz, CDCl3):
δ = 8.92–8.77 (m, 3H), 8.73 (d, J = 8.0 Hz, 1H), 8.13 (t,
J = 8.0 Hz, 1H), 8.06–7.99 (Br–m, 1H), 7.54–7.45 (m,
1H), 7.35–7.28 (m, 5H), 7.20–7.15 (m, 1H), 7.05–6.97 (m,
2H), 3.79 (s, 3H), 3.75 (s, 3H); 13C NMR (125 MHz,
CDCl3): δ = 160.8, 159.9, 159.7, 156.8, 156.2, 155.88,
155.81, 152.31, 149.16, 138.1, 137.1, 137.0, 136.7,
129.74, 129.7X (overlaps with 129.74), 124.23, 124.2,
122.8, 122.5, 122.2, 121.9, 117.2, 116.3, 114.9, 114.4,
55.45, 55.38; IR (ATR-CDCl3): ῡmax = 3065, 3003, 2966,
2835, 1601, 1581, 1502, 1487, 1465, 1379, 908, 781,
731 cmꢀ1; HRMS (EI): m/z calculated for C27H21N5O2:
447.1695; found: 447.1701.
6-{5,6-Bis-[4-(3,3-dimethylbutyl)phenyl]-[1,2,4]triazin-3-yl}-
[2,20]bipyridinyl (16).
MeOH/DCM (gradient); yellow
1
solid; mp = 125.6–130.6°C; H NMR (500 MHz, CDCl3):
δ = 8.82 (Br–d, J = 8.0 Hz, 1H), 8.76–8.67 (m, 3H), 8.08
(t, J = 8.0 Hz, 1H), 7.96–7.91 (m, 1H), 7.71–7.67 (m,
2H), 7.62–7.59 (m, 2H), 7.42–7.37 (m, 1H), 7.25–7.20
(m, 4H), 2.67–2.59 (m, 4H), 1.58–1.49 (m, 4H), 0.98 (s,
9H), 0.97 (s, 9H); 13C NMR (125 MHz, CDCl3):
δ = 160.1, 156.5, 156.0, 153.16, 153.1X (overlaps with
153.16), 147.3, 145.9, 138.76, 138.7X (overlaps with
138.76), 133.1, 132.8, 130.1, 129.6, 128.82, 128.77,
125.3, 124.9, 123.89, 123.8X (overlaps with 123.89),
46.02, 46.01, 31.4, 31.3, 30.77, 30.7X, 29.50, 29.48; IR
(ATR-CDCl3): ῡmax = 3060, 3027, 2953, 2865, 1610,
3-[2,20]Bipyridinyl-6-yl-5,5,8,8-tetramethyl-5,6,7,8-
tetrahydrobenzo[1,2,4]triazine
(20).
EtOAc/
hexanes (gradient); pale-yellow solid; mp = 196.7–
1581, 1562, 1493, 1472, 1382, 1364, 844, 823, 783 cmꢀ1
;
1
200.8°C; H NMR (500 MHz, CDCl3): δ = 8.77 (d,
HRMS (EI): m/z calculated for C37H41N5: 555.3362;
found: 555.3372.
J = 8.0 Hz, 1H), 8.71–8.69 (m, 1H), 8.61 (d,
J = 8.0 Hz, 1H), 8.52 (d, J = 8.0 Hz, 1H), 8.02 (t,
J = 8.0 Hz, 1H), 7.90–7.85 (m, 1H), 7.38–7.33 (m,
1H), 1.87 (s, 4H), 1.51 (s, 6H), 1.45 (s, 6H); 13C
NMR (125 MHz, CDCl3): δ = 164.5, 163.1, 160.9,
156.3, 155.8, 153.0, 149.0, 138.0, 137.2, 124.1,
123.8, 122.3, 121.9, 37.4, 36.6, 33.8, 33.3, 29.9,
29.3; IR (ATR-CDCl3): ῡmax = 2966, 2928, 2854,
6-[5,6-Bis-(4-octylphenyl)[1,2,4]triazin-3-yl]-[2,20]bipyridinyl
(17).
MeOH/DCM (gradient); yellow oil; 1H NMR
(500 MHz, CDCl3): δ = 8.80 (Br–d, J = 8.0 Hz, 1H),
8.74–8.71 (m, 1H), 8.71–8.65 (m, 2H), 8.07 (t,
J = 8.0 Hz, 1H), 7.94–7.88 (m, 1H), 7.70–7.67 (m, 2H),
7.61–7.58 (m, 2H), 7.40–7.36 (m, 1H), 7.23–7.18 (m,
4H), 2.68–2.62 (m, 4H), 1.68–1.59 (m, 4H), 1.37–1.22
(m, 20H), 0.91–0.86 (m, 6H); 13C NMR (125 MHz,
CDCl3): δ = 160.6, 156.4, 156.0, 155.8, 152.7, 148.9,
1582, 1560, 1520, 1474, 1423, 1369, 794 cmꢀ1
;
HRMS (EI): m/z calculated for C21H35N5:
345.1953; found: 345.1957.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet